Cargando…
Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells
Epidemiological studies indicate that metformin, a widely used type 2 diabetes drug, might reduce breast cancer risk and mortality in patients with type 2 diabetes. Metformin might protect against breast cancer indirectly by ameliorating systemic glucose homeostasis. Alternatively, it might target b...
Autores principales: | Rajh, Maruša, Dolinar, Klemen, Miš, Katarina, Pavlin, Mojca, Pirkmajer, Sergej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852933/ https://www.ncbi.nlm.nih.gov/pubmed/27135408 http://dx.doi.org/10.1371/journal.pone.0154747 |
Ejemplares similares
-
Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
por: Bizjak, Maruša, et al.
Publicado: (2017) -
Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α
por: Škorja Milić, Nives, et al.
Publicado: (2021) -
Cell type-specific response to high intracellular loading of polyacrylic acid-coated magnetic nanoparticles
por: Lojk, Jasna, et al.
Publicado: (2015) -
Proposing Urothelial and Muscle In Vitro Cell Models as a Novel Approach for Assessment of Long-Term Toxicity of Nanoparticles
por: Skočaj, Matej, et al.
Publicado: (2020) -
Phosphorylation of Na(+),K(+)-ATPase at Tyr10 of the α1-Subunit is Suppressed by AMPK and Enhanced by Ouabain in Cultured Kidney Cells
por: Petrič, Metka, et al.
Publicado: (2021)